Sonoma Pharmaceuticals Inc Cash Flow-to-Debt Ratio
Sonoma Pharmaceuticals Inc cash flow-to-debt ratio. Sonoma Pharmaceuticals Inc (SNOA) has a Cash Flow-to-Debt Ratio of -0.06x as of June 2026, meaning its operating cash flow of $-649.00K could theoretically repay 0% of its total liabilities ($11.51 Million) in one year. Check how high is Sonoma Pharmaceuticals Inc's earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Sonoma Pharmaceuticals Inc (2005–2026)
Cash flow-to-debt ratio of Sonoma Pharmaceuticals Inc from 2005 to 2026. Historical debt coverage capacity for Sonoma Pharmaceuticals Inc across 22 annual periods. Check cash flow reinvestment rate of Sonoma Pharmaceuticals Inc to assess the company's total reinvestment commitment from operating cash flow.
Sonoma Pharmaceuticals Inc Cash Flow-to-Debt Ratio by Year (2005–2026)
Sonoma Pharmaceuticals Inc cash flow-to-debt ratio by year from 2005 to 2026. Year-by-year debt coverage analysis for Sonoma Pharmaceuticals Inc. For the full cash flow conversion analysis, see SNOA cash generation efficiency.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2026 | -0.36x | $-3.93 Million | $10.87 Million | ▼ -3718.2% |
| 2025 | -0.01x | $-88.00K | $9.28 Million | ▲ +96.6% |
| 2024 | -0.28x | $-2.40 Million | $8.60 Million | ▲ +62.6% |
| 2023 | -0.75x | $-6.15 Million | $8.25 Million | ▼ -78.1% |
| 2022 | -0.42x | $-4.25 Million | $10.15 Million | ▼ -19.3% |
| 2021 | -0.35x | $-3.38 Million | $9.62 Million | ▲ +31.7% |
| 2020 | -0.51x | $-4.59 Million | $8.94 Million | ▲ +82.6% |
| 2019 | -2.96x | $-11.72 Million | $3.96 Million | ▲ +7.7% |
| 2018 | -3.21x | $-12.44 Million | $3.88 Million | ▼ -58.1% |
| 2017 | -2.03x | $-8.17 Million | $4.03 Million | ▲ +15.1% |
| 2016 | -2.39x | $-8.75 Million | $3.66 Million | ▼ -6.8% |
| 2015 | -2.24x | $-6.69 Million | $2.99 Million | ▼ -299.1% |
| 2014 | -0.56x | $-4.89 Million | $8.73 Million | ▼ -513.3% |
| 2013 | 0.14x | $1.15 Million | $8.48 Million | ▲ +129.3% |
| 2012 | -0.46x | $-4.03 Million | $8.71 Million | ▲ +27.2% |
| 2011 | -0.64x | $-4.43 Million | $6.96 Million | ▲ +69.6% |
| 2010 | -2.09x | $-6.64 Million | $3.17 Million | ▲ +60.5% |
| 2009 | -5.30x | $-16.83 Million | $3.18 Million | ▼ -148.5% |
| 2008 | -2.13x | $-17.45 Million | $8.18 Million | ▼ -42.0% |
| 2007 | -1.50x | $-18.08 Million | $12.05 Million | ▲ +60.9% |
| 2006 | -3.83x | $-20.52 Million | $5.35 Million | ▼ -34.3% |
| 2005 | -2.86x | $-13.53 Million | $4.74 Million | — |